China's Geely Auto sold 3,024,567 vehicles in 2025 — a 39% year-on-year increase — deploying full-domain AI across its Comprehensive Safety System 2.0, built on a 'People-Vehicle-Road-Cloud-Satellite' ecosystem.1 The milestone marks a global inflection: AI has moved from research into mass industrialization across healthcare, automotive, fintech, and physical-world systems simultaneously.
Chinese Auto Sets the Global Pace
Geely opened its safety patents to public access — including one-touch window-breaking and underbody battery protection technology.1 When manufacturers from China to Germany to the United States open patents, they are competing on execution, not invention. That threshold has been crossed in the world's largest auto market.
Healthcare Platforms Consolidate
Covera Health and Medmo are merging to build an end-to-end diagnostic imaging platform integrating scheduling, imaging, and quality assurance.2 The model is spreading globally: regulated industries moving from fragmented point solutions to unified platforms that reduce liability exposure. Radiology — one of medicine's most data-intensive fields — is entering AI-driven deployment at scale across North America and Europe.
VC Harvest Cycles Fuel Deployment Capital
Jerusalem Venture Partners logged four exits in Q1 2026 across healthcare and technology.2 Early AI bets from the 2018-2022 enterprise data era are clearing worldwide — from Tel Aviv to Singapore to Silicon Valley — generating liquidity that flows into operational companies, not further R&D rounds.
Two Timelines, One Global Shift
Near-term deployment is broad. AI-assisted diagnostics, automotive safety systems, and enterprise workflows are entering regulated industries now, in H2 2026. Frontier physical-world systems — autonomous vehicle silicon, humanoid robotics, AI-optimized nuclear compute infrastructure — remain 12-30 months from commercial volume.
Healthcare, automotive, and fintech are advancing in parallel across markets — driven by mature models, available compute, and investors globally who need deployment returns, not another research cycle.